Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
about
Phase I Study of Panobinostat + Bortezomib for Relapsed and/or Refractory Mantle Cell Lymphoma (MCL)
description
clinical trial
@en
klinisch onderzoek
@nl
name
Phase I Study of Panobinostat ...... ory Mantle Cell Lymphoma (MCL)
@en
type
label
Phase I Study of Panobinostat ...... ory Mantle Cell Lymphoma (MCL)
@en
prefLabel
Phase I Study of Panobinostat ...... ory Mantle Cell Lymphoma (MCL)
@en
P1050
P1476
A Phase I Study of Panobinosta ...... efractory Mantle Cell Lymphoma
@en
P1813
BUS48T
@en
P3098
NCT01504776
P580
2011-04-01T00:00:00Z
P582
2014-09-01T00:00:00Z